Indonesia vs Sierra Leone: Hepatitis B surface antigen (HBsAg) prevalence
Indonesia
0.7%
in 2024
Sierra Leone
0.7%
in 2024
Indonesia rank
43rd
Sierra Leone rank
43rd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Indonesia
- Sierra Leone
How they compare
Indonesia currently reports 0.7% against 0.7% in Sierra Leone, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Sierra Leone ahead.
Indonesia ranks 43rd and Sierra Leone ranks 43rd of 194 countries.
Across the 2 decades both report, Indonesia averaged higher in 1 and Sierra Leone in 1.
Head to head by decade
| Decade | Indonesia | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 1.3% | 0.4% | Sierra Leone |
| 2020s | 0.8% | 0.8% | 0.0% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Indonesia or Sierra Leone?
- Indonesia, at 0.7% against 0.7% in Sierra Leone as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Indonesia and Sierra Leone?
- 0.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Sierra Leone?
- 10 years are reported by both, from 2015 to 2024.
- How do Indonesia and Sierra Leone rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Indonesia ranks 43rd and Sierra Leone ranks 43rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.